Pasithea Therapeutics Corp.

NASDAQ (USD): Pasithea Therapeutics Corp. (KTTA)

Last Price

3.30

Today's Change

-0.12 (3.50%)

Day's Change

3.30 - 3.45

Trading Volume

8,111

Overview

Market Cap

3 Million

Shares Outstanding

1 Million

Avg Volume

935,268

Avg Price (50 Days)

4.29

Avg Price (200 Days)

5.75

PE Ratio

-0.22

EPS

-14.79

Earnings Announcement

27-Nov-2024

Previous Close

3.42

Open

3.46

Day's Range

3.3 - 3.455

Year Range

3.2 - 17.4

Trading Volume

8,111

Price Change Highlight

1 Day Change

-3.51%

5 Day Change

-7.04%

1 Month Change

-16.46%

3 Month Change

-28.10%

6 Month Change

-50.38%

Ytd Change

-59.01%

1 Year Change

-50.00%

3 Year Change

-93.29%

5 Year Change

-95.37%

10 Year Change

-95.37%

Max Change

-95.37%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment